Updates

Fevertree - Shares break to new highs

March 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

With the benefit of hindsight we clearly should have “buy-rated” premium soft drinks firm Fevertree, whose shares have soared from 714p at the time of our main write-up last August to nearly £13. We have waited for a pull-back but none has emerged. It really is a phenomenal company and has just put out yet another “reverse profit warning” with H2 ’16 sales ahead by 75%, which means full year revenue is now expected to be c. £102.2m. That’s up 73% year-on-year and almost as high as Berenburg’s forecasts for 2018!In response the broker has upgraded eps forecasts by 13%, 11% and 11% for FY’16-FY’18 with new eps of 24p, 25.6p and 28.2p. But they’ve been proven wron ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Nichols

N Brown

Fevertree - Chairman acquires 45,000 shares (March 2024)

Fevertree Drinks - Premium tonic water firm eyes $1.2bn US mixer market (March 2019)

Fevertree (July 2017)

Fevertree Drinks - Brokers upgrade again (September 2016)

Fevertree Drinks - Purveyor of premium tonic water enjoys multiple eps upgrades (August 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X